Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2025-12-24 @ 11:53 PM
NCT ID:
NCT00398151
Eligibility Criteria:
Inclusion Criteria:
* Allergic rhinitis symptoms: sneezing, rhinorrhea, obstruction of the nasal passages, itchy nose and throat, and conjunctival
* Male or female outpatient 20 years of age and older
* Patients with the following signs and symptoms of asthma and allergic rhinitis: history of cough, wheezing, shortness of breath, positive methacholine bronchoprovocation test
Exclusion Criteria:
* Active, acute or chronic, pulmonary disorder (besides asthma) documented by history, physical examination, or chest x-ray. history of anaphylactic or hypersensitive to study drug
* Requires oral, intravenous, or intramuscular corticosteroids on daily routine basis
* Started on immunotherapy within six months before the pre-study visit and/or the dose of immunotherapy is expected to change over the course of the study
* Treated with montelukast within 3 months before enrollment
* Unable to perform acceptable, reproducible spirometry and peak flow measurement
* Unresolved symptoms and signs of an upper respiratory tract infection (uri) within 2 weeks prior to visit 1
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00398151
Study Brief:
Protocol Section:
NCT00398151